PE-backed Aptuit divests two sites to Albany Molecular Research

Aptuit, a portfolio company of Welsh, Carson, Anderson & Stowe, has sold its Glasgow, UK-based aseptic clinical manufacturing site and its West Lafayette, India-based solid-state chemistry business to Albany Molecular Research. The value of the transaction is $60 million. Teneo Capital provided financial advice to Aptuit and Welsh, Carson, Anderson & Stowe.

DealsNorth AmericaUSBriefs